vimarsana.com

Page 4 - தொழில்நுட்பம் நெட்வொர்க்குகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global ICP Optical Spectrometer Market 2020 Research Analysis | Shimadzu, Skyray Instrument, GBC, Thermo Fisher Scientific, Agilent – KSU

Examining the Reproducibility Crisis

  Despite the vital importance of reproducibility to credible science, numerous fields of research continue to experience an ongoing reproducibility crisis, where many findings cannot be independently reproduced and replicated (and some cannot even be replicated by the original researchers themselves).  Download this listicle to learn about: The importance of reproducibility Steps you can take to improve reproducibilityDownload Listicle  

Technology is giving new life to food waste by converting it into biofuel

Food waste accounts for about 22 per cent of municipal solid waste in the United States and produces about eight per cent of the world's human-related

NanoSeq Method Now Detects DNA Mutation in ALL Human Tissue: This Could Help Cancer and Skin Aging Experiments

29 April 2021, 02:04 pm DNA mutation is currently important to solve cancer and skin health issues. And now, some scientists were able to develop a new method called NanoSeq (nanorate sequencing) to detect DNA changes in any human tissue.  (Photo : Photo by Chris Hondros/Getty Images) Marina Kemelman, Research Associate at the AIDS Vaccine Design and Development Laboratory, collects bacteria transfected with DNA as part of research at the laboratory s campus in the former Brooklyn Army Terminal December 1, 2008 in New York City. The laboratory, seeking a vaccine to prevent the spread of AIDS, is part of the International AIDS Vaccine Initiative (or IAVI), a global not-for-profit, public-private partnership working to accelerate the development of a vaccine to prevent HIV infection and AIDS. December 1 is the 20th annual World AIDS Day around the world.

Harnessing T Cells To Detect Disease

Science Writer Adaptive Biotechnologies recently received FDA Emergency Use Authorization (EUA) for T-Detect™ COVID, a test that detects the unique T-cell signature specific to SARS-CoV-2. T-Detect COVID is the first clinical test launched from Adaptive’s TCR-Antigen Map collaboration with Microsoft, highlighting the potential of using T cells in the blood to detect multiple diseases. To learn more about T-Detect, its development and how it compares to antibody testing, Technology Networks spoke to Dr Sudeb Dalai, senior medical director at Adaptive Biotechnologies. In this interview, Sudeb also discusses the role that T-cell analysis may play in the diagnosis and treatment of diseases in the future.  

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.